Feline leukaemia virus and the feline leukaemia virus pseudotype of murine sarcoma (MSV(FeLV)) readily propagate in cat embryo cells. Feline leukaemia virus will rapidly attain high titres even if minimal virus inocula are used initially, and undiminished virus production will be maintained in the chronically infected cells. Feline leukaemia virus, which was previously quantitated as helper activity for defective MSV (FeLV), has now been related to the amount of autonomously replicating feline leukaemia virus. Rapid growth ofMSV (FeLV) to high titre is obtained only if each sarcoma infected cell also becomes the recipient of a replicating unit of feline leukaemia virus. Conditions approximating one-step growth curves for both feline leukaemia virus alone and MSV (FeLV)-feline leukaemia virus complex can be achieved and show that first cycles of growth are completed within about 4o and 3o hr, respectively. The rate of growth of the sarcoma-leukaemia virus complex is somewhat faster than that of leukaemia virus by itself, which can result in ratios of replicating leukaemia to sarcoma viruses of less than unity. Inhibition of DNA synthesis during the first 12 hr after infection with either virus prevents virus replication. The requirement for DNA synthesis is not seen beyond the first I2 hr after infection. No stimulation of DNA synthesis is discernible after either feline leukaemia virus or MSV (FeLV) inoculation at any time after infection.
INTRODUCTION
Murine sarcoma virus derived from mouse tumours generally behaves in tissue culture cells as a focus-forming virus which exists in combination with an excess of some murine leukaemia virus (Hartley & Rowe, I966; O'Connor & Fischinger, 1968; Bassinet al. 1968) .
Sarcoma virus can be considered to be defective because readily detectable loci and new virus growth require a dual infection of a cell with both sarcoma and leukaemia virus infectious units (Hartley & Rowe, 1966; O'Connor & Fischinger, I968) . Apparently, competent murine sarcoma virus, which did not require helper leukaemia virus, has been obtained from tumours and from infected tissue culture (O'Connor & Fischinger, 1968) . The competent form, composed of a union of sarcoma and leukaemia viruses has also been produced in the laboratory from defective murine sarcoma virus and added Moloney, leukaemia virus by centrifugal aggregation (O'Connor & Fischinger, I969a ) . Similar aggregation of defective murine sarcoma virus with feline leukaemia virus (FeLV), allowed the sarcoma virus to transfer and multiply in normally insusceptible feline embryo fibroblast (FEF) cells (Fischinger & O'Connor, 1969a ) . The product of such an infection was a new pseudotype of sarcoma virus -MSV (FeLV) -which possessed an FeLV coat since it could be neutralized with antisera to FeLV and since interference with MSV (FeLV) loci could be seen in FeLV pre-infected FEF cells (Fischinger & O'Connor, 1969 a; Sibal et al. 1970) . The M SV (FeLV) pseudotype was still defective and had the broad host range of FeLV in that it transformed and replicated in cat, dog and human cells but not in mouse cells (Jarrett et al. ~ 968; O'Connor & Fischinger, 1969 b; Jarrett, Laird & Hay, 1969; Chapman, Fischinger & O'Connor, 197o; Fischinger & O'Connor, 197o ) . This paper reports on the quantitative interactions between helper FeLV, replicating FeLV, and MSV (FeLV) in FEF cells. High titres of both viruses were produced so that one cycle growth of each could be examined and the requirement of DNA synthesis for virus replication was established.
METHODS
Viruses and cells. Feline leukaemia virus was obtained from Dr C. Rickard in fragments of neoplastic thymus tissue from leukaemic cats (Rickard et al. 1969) . Dilutions of a I o % tumour extract were used to infect FEF cells and subsequent stocks of FeLV were derived from chronically infected FEF cells. MSV (FeLV) was prepared by co-centrifugation method and passed routinely in the same FEF cells (Fischinger & O'Connor, ~969a) . The FEF cells, media and the mode of propagation were described previously (Fischinger & O'Connor, 1969a; Fischinger & O'Connor, ~97o) . A single source of cat embryo cells was used throughout because of possible genetic differences in susceptibility to FeLV among outbred cats.
Assays of sarcoma and leukaemia viruses. The focus assay for defective MSV (FeLV) in FEF cells was followed as described (Fischinger & O'Connor, I969a ) . Optimal focus visualization required low density of plating (2.o × Io 5 cells/zo cm. 2 plastic dish) and a change of medium on the third day after infection. Every assay consisted of a dual titration of MSV (FeLV) alone and with optimal amounts of FeLV as helper virus (z LVHU/cell, see below) which was added immediately after infection with sarcoma virus. Focus assays were also performed on FEF cells pre-treated for 30 min. with I to 75 #g-DEAE-dextran (Pharmacia) in nutrient medium (Chapman et al. I97O) . Graphing of the focus titration pattern on Hartley & Rowe (I966)-type plots revealed two hit titration patterns indicative of defective virus; a non-defective form of MSV (FeLV) was not evident (< i %).
FeLV was assayed by the helper assay which is based on the increase of loci of defective MSV (FeLV) subsequent to the addition of exogenous FeLV (Fischinger & O'Connor, ~968) . The increase was readily related to the infectious quantity of FeLV as leukaemia virus helper units (LVHU). The standard formulation was recently confirmed by computer models (Hahn et al. I97o) . Additionally, all FeLV stocks and several MSV (FeLV)-FeLV samples were assayed by a terminal dilution method based on the 5o % end-point technique of Reed & Muench 0938) . The end point of replicating FeLV was measured either as the induction of new FeLV helper activity for MSV (FeLV), or as the complete interference to superinfection with looo (f.f.u.) of MSV (FeLV). In more than 50 assays at FeLV end-point dilution, the correlation between induction of new helper virus and interference with homologous sarcoma virus was unity.
Virus growth curves were performed by the infection of cells with FeLV or MSV (FeLV) at the designated m.o.i, for I½ hr at 37 °. The unadsorbed virus was collected and the cells were washed twice. The unadsorbed virus was combined with the wash fluids and the total was assayed to measure the efficiency of virus adsorption. Viruses were harvested by scraping the cells into their supernatant fluid, freezing and thawing once and centrifuging lightly before use 05o0 rev./min. 15 min., at 4°.).
Infectious centre experiments were performed by addition of trypsinized and washed (Hirschman, Fischinger & O'Connor, 1969b) . DNA synthesis was specifically inhibited by 2o mM-thymidine, a concentration which was not toxic to cells and whose effect could be rapidly reversed as described by N akata & Bader (t 968). The rate of synthesis of RNA and the residual DNA synthesis can be readily measured under conditions of a2p incorporation into both types of nucleic acid, which are separable by the SchmidtThannhauser (I945) procedure. ~2p was counted as Cerenkov radiation. Without resorting to pre-treatment of ceils with media low in phosphate, RNA and DNA synthesis were measured under conditions which were biologically exactly analogous to the growth experiments.
RESULTS

Adsorption of FeLV and MSV (FeLV) to feline embryo cells
Adsorption of FeLV by itself and MSV (FeLV) with its endogenous FeLV component were measured under standard conditions of assay. After I½ hr at 35 ° approximately 80 of the virus input of either FeLV alone or MSV (FeLV) and FeLV became cell-associated and could not be washed off, whereas virus inocula were essentially quantitatively recovered from control dishes without cells. The unadsorbed MSV (FeLV) had titration patterns identical to the input virus both in the slope and in the fraction of defective virus expressed. A preferential adsorption of either component would shift the ratio of expressed MSV (FeLV), whereas the identical pattern of focus titration demonstrated that the extent of adsorption of MSV (FeLV) and its endogenous FeLV within a single virus stock were similar.
Because the focus-forming virus titre of several forms of murine sarcoma virus was significantly enhanced in the presence of DEAE-dextran, several stocks of MSV (FeLV) were checked for focus potentiation after pre-treatment of cells with various amounts (I to 75 #g./ml.) of DEAE-dextran. As shown previously, the effect of DEAE-dextran at optimum levels was only a 2-to 4-fold increase in foci; accordingly, untreated FEF cells were used for further virus growth studies (Chapman et al. I97o) .
Production of high titres of FeLV in FEF cells
The original FeLV from lymphoma tissue was inoculated into FEF cells and followed by the helper assay for FeLV during successive cell passages. Prolonged infection of cat cells resulted in no overt morphological alterations. The growth rate of several quantities of tissue culture derived FeLV was measured in fresh FEF cells by the helper assay. As seen in Table I , even highly diluted inocula grew rapidly. After inoculation of high titres of virus, maximum virus titres/cell were seen by 4o hr. With all inocula used FeLV titres reached maximal levels rapidly, so that > io T LVHU/ml. of FeLV was usually found in the supernatant. Cell viability and growth rate after infection were comparable to uninfected FEF 0"2 10 5 8"8 X 10 5 8"8 X 10 6 5'6X 10 6 8'0 × 10 7 2.o 3"3 x io 5 38 x 1o n 1.7 x io 7 6.8 x lO 7 9'3 x io 7 4I 2.8 x lo 6 2.I x IO v N.T. N.T. 9"7 x to T Uninfected cat embryo cells grew as rapidly as FeLV-infected cells. From I "o x I@ viable cells at the time of infection, 5"0 x io 6 cells were present on the fourth day after infection. Maintenance medium was changed on days 3 and 6. Day 14 after infection constitutes virus harvests from cells which were passed once on day 7. N.T., not tested. 
Relationship of FeLV helper activity to replicating virus
Leukaemia virus helper activity, expressed in LVHU, relates specific interactions of defective MSV (FeLV), endogenous FeLV, the target cell population as well as exogenously added helper FeLV. The LVHU titre might therefore reflect varying efficiencies of these interactions rather than the real quantity of leukaemia virus replicating units (LVRU). For several stocks of FeLV of predetermined LVHU titres, terminal dilution assays of FeLV were performed to estimate a 50 ~o replicating virus end point. Under the conditions of testing in these FEF cells, the value of any single FeLV stock in LVRU was consistently about o. ~ of that expressed in LVHU. This discrepancy between LVHU and LVRU could be an artifact produced by rapid spread of FeLV or could be due to defective FeLV particles analogous to those of radiation leukaemia virus (Fischinger & O'Connor, x969b) .
To test for the existence in FeLV stocks of a non-replicating but biologically active helper virus for MSV (FeLV) two types of reconstruction experiment were carried out.
The results of the first are shown in Table z . The rationale was that if IO 5 LVHU of exogenous FeLV allowed the expression of (n) MSV (FeLV) foci in a dish of to 5 cells and if this was a result of dual infection of a cell with one MSV (FeLV) particle and one (or more) LVHU, then a dispersal of such infected cells among ten times as many fresh uninfected cells would still result in (n) loci (actually (n) × e.o.p, due to losses in the infectious centre assay). But if ~o 5 LVHU allowed expression of (n) foci only after one or more multiplication cycles of an LVRU, then dispersal of the cells immediately after infection would result in many fewer foci; however, if Io 5 LVRU (i.e. IO 6 LVHU) of FeLV were included in the original inoculum then all of the (n) loci should be expressed.
To distinguish between these alternatives an experiment was carried out in which cat embryo cells were inoculated with a total of about loo f.f.u./dish of two different stocks of MSV (FeLV) to which either ~-z x IO 5 LVHU or I.z x i08 LVHU of FeLV were added. After 2 hr incubation several dishes of infected cells were washed three times, trypsinized, pooled, and the equivalent of one infected plate of cells (I x Ios cells) was dispersed into I0 to 20 dishes of fresh FEF cells each containing Lo b viable cells, 2o hr old. Three to six of these dishes also received 2 x io a LVHU of FeLV at the same time. Among experiments the e.o.p, of infected cells on to fresh FEF cells and their subsequent detection as loci under presumed optimal conditions varied from o.22 to o'4o. On the fifth day the foci were counted, their numbers were added in the respective sets of dishes and projected in terms of MSV (FeLV) infectious centres that were expressed among the cells of the original infected dish.
As seen in Table 2 for two different virus stocks which were tested, I × IO 5 LVHU were inadequate to visualize MSV (FeLV) as focus-inducing centres on fresh FEF cells unless additional, optimal FeLV was added to the cells of the assay; actually 1.2 x ~0 G LVHU were needed in the original inoculum of about Ioo f.f.u, of MSV (FeLV) to express all the defective MSV (FeLV) as infectious cell centres. In the original infection, which was supplemented by IO 6 LVHU, exogenous FeLV added to the assay plate did not express any additional cells which might have been infected with MSV (FeLV). Quantitatively ~ × ~05 LVHU, which was adequate to express all single hits with MSV (FeLV) in a 5-day assay, was inadequate if the infected cells were significantly separated from each other, which strongly suggests that the high values of FeLV in terms of LVHU were due to a spread of leukaemia virus-replicating units to immediately contiguous cells. Thus the effective target cell population was reduced which in terms of the derivation for helper activity raises the helper unit value (Fischinger & O'Connor, 1968) .
The possibility of the existence of non-replicating helper FeLV within stocks of MSV (FeLV) was examined in a second experiment using a single defective MSV (FeLV) stock (P42). This stock was assayed for its content of endogenous LVRU by the end-point dilution method and was found to have the lowest replicating leukaemia to sarcoma virus ratio available. Since the quantity of both known interacting viruses was fixed, one could accurately predict the probability of expression of MSV (FeLV) as infectious centres at each of two dilutions of this virus stock, and could examine whether LVRU alone were significant in the production of loci from infectious centres. Accordingly, FEF cells were infected with two dilutions of P42 MSV (FeLV). After incubation for 2 hr the cells of several plates were washed, trypsinized and the cell equivalent of one dish (Io b viable cells) was spread among ten dishes of fresh FEF cells, three of which received adequate FeLV to express all defective MSV (FeLV). In Table 3 the number of foci found experimentally as a total sum of foci among plates containing infected cells without added helper, matches closely that expected if only replicating FeLV interacted with MSV (FeLV) to produce visible loci. That is, the expression [(P~sv (r~v) >/ I) (P~vRtr >/ ~) x e.o.p.], which roughly represents the probability that an FEF cell would be the recipient of both an MSV (FeLV) and an LVRU, thereby initiating a productive infection (less the loss of infected cells subsequent to trypsinization and transfer to fresh cells), would predict about 22 to 35 loci, depending on the exact e.o.p, among experiments. The expected number of foci was close to the observed count of 33 foci which is compatible with the interpretation that only FeLV expressed in LVRU contributes to the detection of infectious cell centre foci.
Attainment of high titres of MS V (FeL V)
The progeny of the original foci induced in FEF cells by the centrifugal aggregate of the murine sarcoma virus and FeLV yielded about I × lo 4 f.f.u./ml, when grown on fresh cat cells. Subsequent passage of the undiluted virus in FEF cells resulted in a loss of titre of about one log unit at each passage. Empirically, higher dilutions of MSV (FeLV), a longer infection period, and supplementation with FeLV produced stocks of virus containing more than I × ~o 6 f.f.u./ml. To quantitate the paradoxical condition where a lower input of MSV (FeLV) yielded a higher final titre, several selected combinations of inocula of MSV (FeLV), whose FeLV content in LVRU was known, were used to infect FEF cells. As detailed in Table 4 , production of new infectious MSV (FeLV) was followed after inoculation with three different sarcoma virus inocula. Cell growth and viability were assessed in each case. 
* Based on the probability of dual infection of a cell with a defective MSV (FeLV) and a unit of FeLV (P ~sv~> I) (PF~LV >/ I) in a dish containing I × IO 5 viable cells where FeLV is either an LVRU or an LVHU (Pring, I967).
I" The sum of infectious cell centres registering as foci after plating I × I@ FEF cells infected with 1742 virus on dishes of fresh cells, half of which were supplemented with an optimal amount of exogenous FeLV (z × I@ LVHU). Each count was derived from ten plates.
The e.o.p, of infectious cell centres was o-22, as determined from the ratio of absorbed f.Lu.
•dish to the sum of the foci expressed in the presence of optimal FeLV helper. Feline leukaemia and its murine sarcoma pseudotype 209 became hyper-refractile, and many floated into the supernatant medium. Cell death also became apparent. Two-day virus progeny resulting from a high input of MSV (FeLV) showed ratios of replicating FeLV to MSV (FeLV) which were equal to or less than unity. Inoculation of fewer f.f.u, of MSV (FeLV) produced new virus more gradually and the lowest sarcoma virus input (m.o.i. of o'o5) replicated to yield more than lO 6 f.f.u./ml, in 5 to 6 days. There the cell growth rate was comparable to uninfected cells and the final cell number reached 3 to 5 × lO6 at confluency with relatively few dead cells. It seemed that the production of high titres of MSV (FeLV) was optimal when the viruses recruited rapidly dividing uninfected cells. Cat embryo cells (I x lO 5) were infected with a constant amount of MSV (FeLV) to which small increments of exogenous FeLV were added. Virus progeny was harvested after 48 hr and is expressed as total virus/dish. All sarcoma virus assays were done in fresh FEF cells with optimal FeLV addition (2 x io 5 LVHU/dish).
To determine whether the loss of the sarcoma virus titre subsequent to inoculation of higher m.o.i.s of MSV (FeLV) was due to insufficient replicating FeLV, a stock of MSV (FeLV) with predetermined low LVRU content was supplemented with increasing quantities of FeLV. Total MSV (FeLV) yields were assayed after 48 hr of growth. Table 5 shows that MSV (FeLV) virus production depends on replicating FeLV and that progressively limiting FeLV produces correspondingly less sarcoma virus. Additionally the P42 stock of virus was rapidly passed in I x lO 5 cells every 2 days without exogenous FeLV supplementation. After three such passages the virus titre declined to about 102 f.f.u./ml. In contrast, P42 could be passed rapidly every 2 days without loss of titre (> 105 f.f.u./ml.) if enough FeLV LVRU were added to express alI defective MSV (FeLV) at each passage. Infection with higher m.o.i, of P4 z MSV (FeLV) plus FeLV above 3"0 LVRU/cell produced no more than about 7"0 x io 5 f.f.u./dish.
Conditions approximating one-step virus growth curve
With sufficient input quantities of both replicating FeLV and MSV (FeLV) it was possible to examine the sequence of events occurring during the first cycle of virus replication. The growth of I × IO 5 adsorbed f.f.u, of MSV (FeLV) together with a combined adsorbed content of 2 x io 5 LVRU was followed in 7"3 x IO cells as total virus yield at selected hours after infection. As seen in Fig. I , curve C, infectious sarcoma virus disappeared rapidly until about the Ioth hr, which marked the beginning of a rapid egress of defective MSV (FeLV) which levelled off about the 3oth hr after infection. During that time the MSV (FeLV) titres increased almost three log, while the total number of cells (which were 85 ~o viable) increased only threefold. Virus harvested at 72 hr after infection had a severely reduced MSV (FeLV) content (< 2o 4 f.f.u./dish). The total number of cells failed to increase after 36 hr and stabilized at about I x lO 6 with approximately so ~ floating non-viable cells. Growth of FeLV alone was then measured under conditions where an adsorbed input of 2 × io 6 LVHU (2 x io n LVRU) was used to infect 7"3 x io ¢ viable FEF cells. As seen in Fig. 2 , curve C, input FeLV also eclipsed rapidly and new virus production commenced about the ruth hr after infection. The rate of replication was slower than that of MSV (FeLV) and failed to reach a plateau. The growth rate of infected cells was exactly that of uninfected control cultures. Between 36 and 72 hr after infection, the augmented virus titre correspond to an increased number of viable cells. The time of appearance of infectious sarcoma leukaemia virus complex was more rapid than that of the leukaemia virus alone, suggesting that the sarcoma virus moiety could replicate more rapidly in FEF cells once the helper requirement by FeLV has been met or, alternatively, the linked multiplication of MSV (FeLV) and FeLV also increased the rate for endogenous FeLV.
Transient requirement of DNA synthesis for FeL V replication
Necessity for DNA synthesis in FeLV multiplication has not been demonstrated as yet, although it is a 'C' type RNA virus and has an associated RNA dependent DNA poly- (Jarrett et aI. I968; Spiegelman et aL I97O ) . Under conditions which approximate one step growth, the effect of inhibition of DNA synthesis should appear most prominent. Thymidine was chosen as the specific, readily reversible and essentially non-toxic inhibitor of DNA synthesis. Analogous to previous reports in rat cells, treatment of FEF cells with zo mM-thymidine inhibited 9o ~ of DNA synthesis and was readily reversible, whereas RNA synthesis persisted at levels greater than 50 ~ (Nakata & Bader, ~ 968) . Treatment with thymidine consisted either of pre-treatment of cells for 8 to I6 hr immediately before infection, during the whole growth cycle, or at selected time intervals during the growth cycle. Fig. I and 2 combine all the treatment times and intervals with thymidine. Subjecting FEF cells to thymidine for I2 hr and allowing a I hr recovery time before infection had essentially no effect on the quantity of FeLV or MSV (FeLV) produced throughout the growth cycle. Constant treatment of FEF cells with thymidine completely inhibited new synthesis of either virus. FeLV, and by inference MSV (FeLV), was sensitive to thymidine and required DNA synthesis before 12 hr after infection, whereas treatment with thymidine after i2 hr was essentially ineffectual. The presence of thymidine during the sensitive time of P.J. FISCHINGER AND D. K. HAAPALA virus synthesis reduced the total virus produced by about 3 log units. A limited treatment with thymidine for 12 hr followed by reversal was initially inhibitory to virus growth but later some synthesis of virus occurred,
Effect of FeLV and MSV (FeLV) infection on DNA synthesis
Infection of mouse or rat cells with murine sarcoma leukaemia virus complex resulted in either inapparent or slight stimulation of DNA synthesis during infection (Nakata & Bader, i968; Hirschman, Fischinger & O'Connor, I97O ) . Under conditions approaching one-step virus growth, it became possible to see whether virus infection stimulated DNA synthesis during the time when DNA function was mandatory for virus growth. Accordingly, the rate of DNA synthesis was measured as the [3H]-thymidine incorporated into DNA during a I hr pulse, done every hr after infection. The number of cat cells and the quantities of MSV (FeLV) or FeLV alone were identical to those in the one-cycle growth curve. After plating, cat cells exhibited some synchrony of DNA synthesis every 12 hr similar to that described for the chicken cell Rous sarcoma virus system (Temin, 1967) . Experiments were performed on two batches of cells where the first and the second infection with MSV (FeLV) or FeLV alone were separated by an interval of half the division cycle of FEF ceils (6 hr). Virusspecific DNA synthesis could be more apparent if it were separable from the bulk of cellular DNA synthesis. Neither the infection with FeLV or MSV (FeLV) stimulated DNA synthesis over the control values at times after infection where virus-specific DNA synthesis was operant. After 3o hr of infection a distinct diminution of DNA synthesis occurred in the MSV (FeLV)-producing cells but not in control or FeLV-infected cells. DNA synthesis reached very low levels, of about 15 ~ the control or FeLV infected cell value, between the 5oth and 7oth hr, which is commensurate with cell death and the reduced cell number in the sarcoma virus infected cells (Table 4) .
DISCUSSION
Quantitative interactions of FeLV and defective MSV (FeLV) were followed in FEF cells with respect to the development of high titres of leukaemia and sarcoma viruses. Random passage in FEF cells of MSV (FeLV)-FeLV complex, whose components were not specifically quantitated resulted in a rapid loss of focus-forming virus. Formation of MSV (FeLV) by rescue from MSV induced hamster tumour cells and subsequent passage in cat cells also gave low titres of focus-forming virus (Sarma, Log & Huebner, I97O) . A high titre of MSV (FeLV) could be routinely maintained by supplementing defective MSV (FeLV) with enough replicating FeLV that each multiplying cell received both infectious units. In FEF cells, as well as in mouse cells, a dual infection of a cell by both sarcoma and leukaemia virus genomes leads to an altered cellular appearance, new virus production, and lysis of cells. Studies in which a majority of cells is dually infected and produces both FeLV and MSV (FeLV) suggested that infected cells are able to undergo several divisions before lysis. The apparent steady state of sarcoma virus titre late in infection probably reflects complex conditions of cell growth and death as well as thermal inactivation of virus plus residual virus growth (Purifoy, Purifoy & Sagik, I968 ) .
A specific advantage of the cat embryo cell system for the replication of the murine sarcoma virus genome lies in the production of low amounts of replicating FeLV. Previously large excesses of endogenous leukaemia virus were present with the sarcoma virus which make interpretations of the nature of the murine sarcoma virus at the molecular level difficult. Because the murine sarcoma virus can now be obtained in two unrelated species in association with low amounts of dissimilar leukaemia helper viruses, comparative studies should be able to ascertain the specific nature of the sarcoma virus genome and antigens.
In the infectious cell centre assay presumably ' defective' FeLV, which could act as helper but not replicate, was not apparent in our cat leukaemia virus stock and the constant higher titres of FeLV expressed in LVHU rather than LVRU seems to be due to contiguous spread of replicating FeLV to rescue MSV (FeLV) present as single hits in surrounding cells. The helper assay can express leukaemia virus titre in LVRU if the derivation for helper activity is modified to account for the spread factor of leukaemia virus within that system.
Recent developments describing RNA-dependent DNA polymerase as components of all oncogenic RNA viruses, including FeLV, clarify the apparent need for intact DNA synthesis for virus growth (Temin & Mizutani, I97o; Spiegelman et al. I97o) . Murine leukaemia virus and its pseudotype of sarcoma were previously shown to require intact DNA synthesis for replication in mouse cells and for transformation in rat cells (Nakata & Bader, 1968; Hirschman et aI. I969a; Hirschman et al. I969b) . Growth studies of FeLV as well as MSV (FeLV) have shown requirement for DNA synthesis. During one-step virus growth the effect of specific inhibition of DNA function is magnified and the transitory nature of the event is especially prominent. Stimulation of DNA synthesis is not seen at any time after infection with leukaemia virus alone or with MSV (FeLV) inocula ten times as high as those reported to cause stimulation of DNA synthesis by murine sarcoma virus in mouse cells (Hirschman et al. I97o ).
An extrapolation of quantitative interactions between sarcoma and helper viruses from animal model systems may facilitate a possible elicitation of human oncogenic viruses as replicating entities and clarify the difficult question of causal relationship between human candidate viruses and human neoplasia.
